Urologix Inc. (ULGX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Employees:
61
14405 21ST AVE N, MINNEAPOLIS, MN 55447
6124751400

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 87.271 Thousand Shares Outstanding21.818 Million Avg 30-day Volume 49.326 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.06
Price to Revenue0.3189 Debt to Equity-0.6613 EBITDA-3.45 Million
Price to Book Value0.0 Operating Margin-32.297 Enterprise Value8.687 Million
Current Ratio0.555 EPS Growth0.08 Quick Ratio0.307
1 Yr BETA -1.1156 52-week High/Low 0.0 / Profit Margin-38.2937
Operating Cash Flow Growth90.7654 Altman Z-Score-36.2534 Free Cash Flow to Firm 1.141 Million
View SEC Filings from ULGX instead.

View recent insider trading info

Urologix Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ULGX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ULGX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MADSON SCOTT M. CHIEF FINANCIAL OFFICER

  • Officer
 0 2015-04-01 0

EMERY SIDNEY W JR

  • Director
 235,278 2014-11-19 0

DANN MITCHELL

  • Director
 602,388 2014-11-06 0

SPANGLER PATRICK D

  • Director
 155,257 2014-11-06 0

BARYS CHRISTOPHER R

  • Director
 155,257 2014-11-06 0

FLUET GREGORY CEO

  • Officer
  • Director
 289,374 2014-08-13 0

ACKERMANN LISA A EVP, SALES AND MARKETING

  • Officer
 139,132 2014-08-13 0

SMRDEL BRIAN J CHIEF FINANCIAL OFFICER

  • Officer
 15,000 2013-08-14 0

WARREN STRYKER JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 457,280 2012-06-29 0

CARDINAL RALPH PETER VP RESEARCH & DEVELOPMENT

  • Officer
 10,000 2011-09-09 0

MOORE WILLIAM M

  • Director
 78,154 2009-11-16 0

JACKSON GUY C.

  • Director
 16,774 2009-11-10 0

WEBER REBECCA J DIR. OF FINANCE & CONTROLLER

  • Officer
 0 2009-08-06 0

STARKS DANIEL J

  • Director
 30,000 2008-11-11 0

CIRINO JERRY C

  • Director
 0 2008-11-11 0

PARKS FRED B CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 100,000 2007-11-02 0

LINDSOE ELISSA JEANETTE CHIEF FINANCIAL OFFICER

  • Officer
 5,000 2007-10-31 0

DOERFERT KIRSTEN SR VP AND GEN'L MGR

  • Officer
 18,989 2007-10-30 0

TIHON CLAUDE CHIEF TECHNOLOGY OFFICER

  • Officer
 0 2006-10-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments